12:00 AM
Mar 23, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

CytRx preclinical data

In a rat model of diabetes, iroxanadine improved diabetic peripheral neuropathy as measured by sensory nerve conduction velocity (SCNV)...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >